Mycoplasma Haemofelis

''Mycoplasma haemofelis'' is an epierythrocytic parasitic bacterium. It often appears in bloodsmears as small (0.6 μm) coccoid bodies, sometimes forming short chains of three to eight organisms. It is usually the causative agent of feline infectious anemia (FIA) in Canada and the United States.

The ~1.15 Mb genome contains a minimalistic assortment of genes limited to the most basic cellular functions. This leaves ''M. haemofelis'' inextricably dependent upon its host for the provision of amino acids, cholesterol, vitamins and fatty acids. The complex and specific conditions that the bacterium requires have made it impossible to culture outside a host thus far.

Arthropod vectors are thought to be the primary source of infection, although ''M. haemofelis'' is also known to be transmitted from queen to kitten and following blood transfusion. Immunocompromisation and/or coinfection with FeLV, FIV and other ''Mycoplasma'' species can exacerbate symptoms or cause symptoms to arise in previously asymptomatic individuals. Symptoms include anemia, lethargy, fever, and anorexia.

In suspected cases polymerase chain reaction (PCR) tests have become common and commercially available. There is not yet available test that can confirm or deny the presence of infection in the body. Negative PCR doesn't always exclude whenever the cat is infected or not. Furthermore, multiple peripheral blood smears are recommended to perform prior to excluding the disease.

Recent evidence suggests that ''M. haemofelis'' may be transmissible to humans.

Classification

''Mycoplasma haemofelis'' belongs to the phylogenetically diverse class Mollicutes, which comprises eight genera: '' Ureaplasma'', '' Spiroplasma'', '' Asteroleplasma'', '' Mesoplasma'', '' Entomoplasma'', '' Acholeplasma'', '' Anaeroplasma'', and ''Mycoplasma''. '' Haemoplasmas'' is the name given to the trivial cluster that includes ''M. haemofelis'' and its close relatives.

Before the advent of modern PCR techniques, ''M. haemofelis'' and closely related Haemoplasmas ''Candidatus Mycoplasma haemominutum'' and ''Ca. Mycoplasma turicensis'' were collectively classified as '' Haemobartonella felis'' based on similarities in gross morphology. (The '' Candidatus'' distinction is given to newly described species in which additional evidence is required to support their classification.) Jensen et al. 2001 find ''M. haemofelis'' is probably more virulent than ''M. haemominutum''. The inability of researchers to culture many ''Mycoplasma'' spp. ''in vitro'' has made classification difficult. PCR analysis of 16S rRNA sequences of '' Haemobartonella'' spp. showed greater similarity to those of Mollicutes than to those of the family Anaplasmataceae in the order Rickettsiales to which they were previously thought to belong.

PCR-based assays have provided evidence that the Ohio variant and California variant of ''H. felis'' are in fact distinct species, ''M. haemofelis'' and ''Ca. Mycoplasma haemominutum'' respectively. A third Haemoplasma, '' Mycoplasma turicensis'', was later identified in domestic cats. Haemoplasma species have also been identified in dogs ('' M. haemocanis''), mice ('' M. haemomuris''), opossum ('' Ca. M. haemodidelphis''), and alpaca ('' Ca. M. haemolamae'').

Transmission

Although ''M. haemofelis'' is generally the least prevalent of the three known feline Haemoplasmas, it causes the majority of FIA cases in the United States. Blood-sucking arthropod vectors including fleas, mosquitoes and ticks are thought to be the primary mode of dissemination of ''M. haemofelis''. Transmission from queen to kitten has also been observed, however, it is unclear whether this takes place ''in utero'', during birth or through nursing. ''M. haemofelis'' has been transmitted by transfusion and oral administration of infected blood. Males show a significant disposition toward ''M. haemofelis'' infection. It is thought that biting and scratching may result in the infection of toms involved in aggressive behavior. Non-flea means of transmission are believed to exist because Jensen et al. 2001 find high prevalence in an area with low prevalence of flea infestation.

Pathogenesis

Through reductive evolution, the average genome size of ''M. haemofelis'' has been decreased to 1.15 Mb. It has shed many biosynthetic systems found in related gram-positive bacteria as well as the ability to secrete a cell wall (rendering it technically gram-negative). This reduction of genetic information has committed ''M. haemofelis'' to a parasitic lifestyle in which it is entirely dependent upon host cells for the amino acids, fatty acids and vitamins for which it has lost the ability to synthesize. Consistent with its parasitic lifestyle, the ''M. haemofelis'' genome contains a significant number of genes devoted to adhesins, resistance to oxidative stress and the production of variable surface antigens that allow it to persist in the host.

Once in the bloodstream, ''M. haemofelis'' individuals adhere to the cell membranes of red blood cells and eventually become partially embedded. After a delay of 2 to 34 days, the acute phase of infection occurs, during which marked parasitemia is often observed. In some cases, up to 90% of red blood cells become parasitized. During this stage of infection, ''M. haemofelis'' organisms can be identified in a stained blood smear under light microscopy.

Synchronous phase variation has been observed in natural ''M. haemofelis'' infections during which rapid fluctuations in parasitemia are observed. This spontaneous alteration of phenotype seems to allow individuals to detach from erythrocytes by the alteration or concealment of surface antigens. This may facilitate the persistence of ''M. haemofelis'' within the host by disguising or eliminating antigens that might elicit an immune response.

Parasitized red blood cells often lose their biconcave shape. This decreases surface area, increases osmotic fragility, and increases the likelihood that these cells will be captured and destroyed by the spleen. The attachment of ''M. haemofelis'' to red blood cell membranes is often associated with positive Coombs test results, meaning IgG antibodies have become bound to red blood cells, marking them for destruction. For the most part, the anemia seen in ''M. haemofelis'' infection is a result of extravascular erythrophagocytosis by macrophages in the spleen, liver, lungs, and bone marrow.

Left untreated, as many as one-third of cats with acute ''M. haemofelis'' infection will die from severe anemia. In cats that mount adequate immune and regenerative responses to acute infection, a recovery time of a month or more may be required before the hematocrit returns to normal. During this recovery time, ''M. haemofelis'' is often observed to remain in circulating blood, but in decreased numbers. Cats that recover from acute infections may remain infected for life. Intact ''M. haemofelis'' organisms have been observed in the phagocytic vacuoles of splenic and pulmonary macrophages, suggesting that these cells may serve as reservoirs.

Co-infection with FIV, FeLV and ''Candidatus Mycoplasma haemominutum'' is common. Although ''M. haemofelis'' infection can cause acute hemolytic anemia in otherwise healthy cats, immunosuppression, including that brought on by retroviral pathogenesis, increases susceptibility to the most severe effects of ''M. haemofelis'' infection. In some cases, infected cats may remain asymptomatic carriers until compromising of the immune system permits increased parasitemia and the onset of acute symptoms. Chronic ''M. haemofelis'' infection may promote neoplastic transformation of white blood cells in FeLV-infected individuals.

Diagnosis

In suspected cases, ''M. haemofelis'' can be identified by polymerase chain reaction analysis for species-specific 16S rRNA sequences, as well as by light microscopy. Treatment usually includes the administration of doxycycline or enrofloxacin to quell the infection along with transfusion and administration of glucocorticoids to alleviate anemia. Jensen et al. 2001's PCR assay diagnoses either or both of ''M. haemofelis'' and ''M. haemominutum'' – this is useful because they find coinfection with both is common. Several other teams also find haemoplasma coinfection is common. It was developed by Jensen et al. 2001 and also published with their own trials, which showed 17.1% of individuals suspected of haemoplasmosis did suffer from this species. Jensen also find ''none'' of the asymptomatic controls had this species, although some did suffer from ''M. haemominutum''. Foley et al. 1998, Tasker et al. 2003, Westfall et al. 2001, Berent et al. 1998, Jensen et al. 2001, Tasker et al. 2003 demonstrate that PCR is more sensitive than cytology for haemoplasmas.

The severity of disease produced by ''M. haemofelis'' varies, with some cats having mild anemia and no clinical signs and others having marked depression and severe anemia. Clinical signs include lethargy, anorexia and anemia. ''M. haemofelis'' infection is suspected in cats with regenerative anemia, in which polychromasia and reticulocytosis are noted. During the acute phase of infection, ''M. haemofelis'' can be readily identified on stained blood films, however, ''M. haemofelis'' can disappear and reappear in the peripheral blood throughout the course of infection and can be mistaken for stain precipitate, or vice versa. Commercially available PCR assays that detect the ''Mycoplasma'' 16s rRNA are a more reliable means of diagnosis. Many such assays are species-specific. Currently, no serological test for ''M. haemofelis'' is commercially available. Additional clinical findings may include positive Coombs test results, hypoglycemia and dehydration.

Treatment

Antibiotic treatment is indicated only for Haemoplasma-positive cats that present clinical signs for FIA. While it is not believed that ''M. haemofelis'' can be completely eliminated, regimens of doxycycline or enrofloxacin are effective in reducing bacteraemia. Doxycycline and enrofloxacin combat ''M. haemofelis'' infection by interfering with translation and DNA synthesis respectively. These antibiotics carry side effects including esophagitis, GI disease and retinal damage and are thus primarily administered only to cats suffering from acute infection with clinical signs. Furthermore, blood transfusion and administration of glucocorticoids relieve the severe anemia resulting from ''M. haemofelis'' infection of erythrocytes. Treated and untreated animals that recover from ''M. haemofelis'' infections generally remain carriers but seldom relapse with clinical disease. One clinical study shows that a treatment with Doxycycline/Marbofloxacin can clear the bacteremia and fully cure the cat from infection – (Consecutive antibiotic treatment with doxycycline and marbofloxacin clears bacteremia in Mycoplasma haemofelis-infected cats Marilisa Novacco et al. Vet Microbiol. 2018 Apr.)

Public-health implications

Arthropod vectors appear to be the primary mechanism of ''M. haemofelis'' transmission. ''Mycoplasma'' DNA sequences have been detected in fleas, ticks and mosquitoes. Given that humans often cohabit with cats and that species of blood-sucking arthropods inhabit most temperate regions, transmission of Haemoplasmas to humans appears possible. Furthermore, all three feline Haemoplasma species have been detected in wild felids, suggesting the possibility that they may act as reservoirs of infection for arthropod transmission. In 2008, ''M. haemofelis'' was detected in an AIDS patient from Brazil. The zoonotic potential of ''M. haemofelis'' has yet to be fully assessed, but care should be taken when handling blood or tissue from infected cats.

References

Further reading

*

{{Taxonbar, from=Q3869018

haemofelis
Pathogenic bacteria
Bacteria described in 2002